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1. Introduction 
Information technology (IT) and Web-based facility have become the major backbone of the 
modern hospital information systems (HIS) since the beginning of 21st century. Associated 
with the rapid evolution of medical informatics, the clinical decision support system (CDSS) 
is playing an important role to help physicians and other healthcare professionals in making 
decisions while determining diagnosis of patient data. For the routine treatment procedure, 
the physicians usually take much time to study patients’ clinical records (PCRs) prior to 
explain abstruse clinical markers to patients in clinics. Particularly, for chronic and traceable 
diseases, they also need to refer patients’ quality of life (QOL) and their patient-reported 
outcomes (PROs) for prescribing the proper therapies. Therefore, a real time clinical decision 
support system (RTCDSS) is proposed for patient- and clinician-oriented interface as well as 
patient-to-clinician (P2C) communication, mostly for the chronic diseases with traceable 
clinical markers. The system provides accurate medical informatics with efficient process for 
presenting immediately analytical diagram through graphical interface based on patients’ 
and clinicians’ requirements. 
The major cancer therapy usually brings numbers of side effect in addition to destroy 
tumors. It implies that QOL is deeply impacted by uncertainty and after-effect due to 
treatment of oncology clinic. Healthcare people probably make incorrect judgments because 
patients embarrass on answering private questions or hiding actual conditions. The past 
studies showed improvements for drug dosing, preventive care, and other economic aspects 
of medical care, but not convincingly for diagnosis, as reviewing computer-based CDSS on 
clinician performance and patient outcome (Johnston et al., 1994; Hunt et al., 1998). 
Obviously, it is not easy to create a universal system for varied clinical requirements. 
However, it would be possible to build up a platform with expandable components for 
specified clinical purpose due to customized rules. Therefore, the proposed RTCDSS can be 
induced by developing a patient-oriented interface with healthcare function to collect real 
time PROs and PCRs according to practical requirements of hospitals. For example, the 
assessment of QOL utilizes questionnaires provided by the EORTC1 to highlight physicians’ 
awareness of patients’ status and greatly facilitate physician-patient communication 
(Detmar et al., 2002). Recently, an interactive assessment system named clinical infometrics 
                                                 
1 European Organization for Research and Treatment of Cancer 
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was established with information and psychometrics technology for measurement, 
statistical modeling, informatics and practice, in palliative care with computerized 
procedure to improve clinical assessment (Chang et al., 2007; Chang, 2008). Applied for 
measurement and management of PROs, infometrics technique can assist clinicians to more 
precisely recognize actual response of patients and improve the quality of care with instant 
process and real time outcomes statistics (Lin et al., 2010). With graphical diagrams, 
clinicians thus can convince patients by presenting PRO instantly with other PCR. 
In clinical practice, furthermore, clinicians meet a number of common problems when it 
comes to improving quality of clinical treatments as follows: (1) clinicians may take several 
hours, or even a couple of days, to review PCRs but only have a few minutes to explain their 
opinions to patients; (2) patients typically find difficulty to understand their condition since 
clinicians may only explain the disease adequately using written descriptions; (3) the CDSS 
is computerized, but it may not have online capability in many clinics; (4) real-time analysis 
is not supported by many commercial computational tools. From clinical data tracking to 
real-time decision making tools, the flexible Web-based CDSS with online evidence-based 
medicine (EBM) progress is a growing trend in advanced clinical care The past research 
indicated that publicly released clinical evidence data assist to improve patient care quality 
at the hospital level (Fung et al., 2008). Numerous CDSS platforms have been constructed 
for a variety of clinical approaches. To facilitate the treatments, many studies suggested 
analytical tools to assist clinicians in estimating the relative pretreatment parameters and for 
tracking the proper diagnostic guidelines on visualized interfaces (Holmes-Rovner et al., 
2005; Walter & Covinsky, 2001; Dorfman et al., 2010). Thus, a clinician-oriented interface 
with real-time online analysis may improve accuracy and efficiency of decision support. 
Many clinicians hence are in need of an expandable RTCDSS with an interactive 
diagrammed interface to efficiently evaluate instant informatics and to make clinical 
decisions (Lin et al., 2011). It is feasible to take chronic diseases with traceable markers as the 
case study of RTCDSS. 
In order to solidify real time functions of the proposed system, the clinical guideline with 
medical evidences is recommended for appropriate treatments. The Web-interfaced process 
has been developed for graphical guidelines that allow users to traverse the algorithm by 
flowcharts in an interactive fashion (Liem et al., 1995). The clinical benefits were highlighted 
by rapid knowledge acquisitions, shareable guideline models, and robust information 
systems while evaluating its impacts on outcomes (Zielstorff, 1998). Thus the electronic 
guidelines improved decision quality and physician-patients interaction significantly (Hsu 
et al., 2005). However, many obstacles were encountered as practicing guidelines for the 
management of workflow integration would be the most difficult tasks (Maviglia et al., 
2003). Obviously, lots of challenges still exist while integrating a new RTCDSS with the 
PROs, PCRs, CDSS, and interactive guidelines into the legacy HIS. The framework for 
interactive clinical guidelines should consider readiness of clinicians for practice, barriers to 
change as experienced by clinicians, and the target level of interventions (Moulding et al., 
1999). To properly integrate electronic clinical guidance into an existing system, the issues of 
heterogeneous data integration should be practiced in the platform. Numerous studies 
established models of evidence-based guidelines by using XML (extensible mark-up 
language) documents (Shiffman et al., 2000; Sanders et al., 2001) and AJAX (asynchronous 
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JavaScript and XML) technique to supply shareable information and user-friendly search, 
respectively, with automatic completion. The techniques have been widely utilized to online 
interactive interface in the past years for acquisition of efficient data transportation. 
In this article, prostate cancer, which is familiarly monitored by prostate specific antigen 
(PSA) and other treatment parameters, is taken to practice the proposed RTCDSS. A Web-
based platform is established with clinical infometrics and interactive guidelines for a 
RTCDSS. JavaTM technologies are applied to create patient- and clinician-oriented interfaces 
with automatic clinical procedure and data transformation. 
2. Development of RTCDSS infrastructure 
This section will describe the details how the Web-based platform of RTCDSS is built upon 
novel Internet technologies. The infrastructure involves core models as follows: model view 
controller (MVC), object oriented mapping (ORM), clinical data warehouse (CDW), Web 
services (WS), online analytical process (OLAP), and AJAX. Data flows throughout all stages 
of the structure can be manipulated by Internet services and information techniques. 
2.1 Model-view-controller model 
The MVC model is a type of design patterns employed in software engineering. It 
hybridizes the design patterns, and divides system responsibilities into three parts: the 
model, which maintains program data and logic; the view, which provides a visual 
presentation of the model; the controller, which processes user input and makes 
modifications to the model. Herein, it is utilized for generating a modelized architecture 
systematically with expandable and reusable components of the Web-based platform for 
efficient and flexible collaboration. The concept of modelized architecture can be driven into 
Web assessment for acquiring PROs from online infometrics system and adapting PCRs 
with the legacy HIS in hospital. The architecture reflects the MVC design pattern, which was 
established in 1970’ and included several design patterns to build reliable object-oriented 
software system (Krasner & Pope, 1988). The public of design patterns was first made by 
introducing twenty-three patterns related to creational, structural and behavioural models 
for software design to progress recurrent elements (Gamma et al., 1994). The MVC 
theoretically hybrids three of them, the “strategy,” “observer,” and “composite” patterns; 
and divides system responsibilities into the model, the view, and the controller. The pattern 
is involved in well-known open-source framework such as “Strut,” “Spring,” “Hibernate” 
for development. These frameworks with MVC paradigm use polling for its input control to 
solve the problems on consuming computation resources when the user is not interacting 
with the interface and avoid unnecessary performance loss. Due to this architecture, a web-
based prototype system built with the open-source framework is available for online 
infometrics of QOL. Fig 1 presents an architecture consisting of conceptual components 
organized by three main groups which contain the model, the view, and the controller to 
provide sole modules but support one another for system requirements. 
As extending the MVC-based architecture to the RTCDSS, the built-in elements within the 
framework should be reusable and extractable to enable clinical analysis and decision 
support for clinical cares which includes: (a) instantaneous disease evaluation, (b) risk 
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analysis, and (c) treatment guidance. For these tasks, the infrastructure can be detailed 
below to complete requests for presentation, management, analysis, and database. 
 
Fig. 1. Web MVC-based Architecture with model-view-controller components. 
i. Models: 
The models are leading four main groups: disease evaluation, risk analysis, treatment 
guidance, and data processing models. The first three models are relative to clinical data 
computation while the last one represents the other IT modules. The disease evaluation 
contains modules primarily to retrieve clinical variables, calculate pretreatment parameters, 
and evaluate PROs and PCRs. The risk analysis model drives algorithms to analyze clinical 
variables and parameters, identify risk indicators and criteria, and so on. The guidance 
criteria model enables the generation of evidence-based diagrams, online guidance and 
decision support. The rest of the IT-related modules such as clinical data conversion, 
database connection, and graphical display, are included in the data processing model. 
ii. Views: 
The views can implement the patient- and clinician-oriented interfaces directly with the 
OLAP portal and the EBM informatics for clinicians at the presentation stage. Similarly, the 
view of management interface provides IT engineers with security administration at the 
management stage. Meanwhile, all clinical data can be taken care through the analysis view 
at the analysis and database stages. Based on this consideration, these views are behind the 
major components of each stage such as real-time diagrams, interactive guidelines, privilege 
administration, informatics management, data filtering and data analysis tools. 
iii. Controllers: 
The controllers support interactions among the models and views within the RTCDSS 
infrastructure. At the presentation stage, the controllers process data flow transformation 
and data input validation when the clinicians begin online inquiries. At the management 
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stage, the privilege control and role identification are required when the engineers are 
conducting system maintenance. Meanwhile, the clinical data at the back stages of analysis 
and database are coordinated by heterogeneous data transaction. 
2.2 Object relation mapping model 
Object-relational mapping (ORM) is a programming technique to convert data between 
incompatible type systems in relational databases and object-oriented languages. It is the 
automated and transparent persistence of application objects to the tables in a relational 
database by using metadata that describes the mapping between the objects and the 
database. The ORM works through reversibly transforming data from one representation to 
another and is used to unify various data format transformed among the sub systems 
(Bauger & King, 2005). We can coordinate the infometrics and clinical data flow through the 
interface of ORM to convert persistent objects and manage data transaction and resource 
throughout database. The interface includes functional modules of session, session factory, 
configuration, transaction, query, and criteria to interact XML metadata with application 
modules of server. In mechanism, the session interface conducts lightweight instances of 
application in safe as the necessary data are requested on the web tier all the time; the 
application obtains session instances from a session factory to share many application 
modules and cache scripted database transaction and other mapping metadata at runtime 
for data conversion. Then, the configuration interface configures the location of mapping 
documents and specific properties for data retrieval; thus a transaction interface is 
optionally selected to keep portable between different execution environments. 
Furthermore, the query interface performs instances to control data queries against the 
database, while the criteria interface executes queries under the objected-oriented criterion. 
Herein, the assessment of QOL questionnaires can be implemented by the ORM model for 
online analysis to concurrently process and share light weight data over the Web-based 
system by rearranging storage, organization, and retrieval of structured data. 
2.3 Clinical data warehouse model 
The data warehouse is known as an integral database for historical data repository with lack 
of systematic arrangement by information technique. It was initially defined as an 
integrated, subject-oriented, time-variant and non-volatile database that provides support 
for decision making (Inmon & Kelley, 1994). The concept of clinical data warehouse obeys 
the definition above to integrate practical PROs and PCRs with a standard procedure from 
different hospital databases into the knowledge bank for advanced analysis. To incorporate 
infometrix data with existing PCR for online analysis, a clinical data warehouse (CDW) is 
planned and practiced in the RTCDSS. The data warehouse is known as building up an 
integral database for historical data repository with lack of systematic arrangement by 
information technique. The critical factor leading to the use of data warehouse is that a data 
analyst can perform complex queries and analyses without slowing down the operating 
system. The raw data for clinic in variety of format would be rigorously unified by extract-
transform-load (ETL) process into database through extraction, consolidation, filtering, 
transformation, cleansing, conversion and aggregation (Rob & Cornel, 2004). As planning 
the data warehouse, fact tables and cube dimensions related to historical data are the key 
elements. The fact table contains facts that are linked through their dimensions, which are 
qualifying characteristics that provide additional perspectives to the given facts. 
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2.4 Web services model 
A Web service is an interface describing a collection of operations that are network 
accessible through standardized XML messaging (Gottschalk et al., 2002). With the Web 
services model, the criterion for decision support can be retrieved from online data logs for 
online analysis. Through Web services, the computation model retrieved decision criteria 
from unified document to create online statistical chart. In order to improve efficiency of 
data transaction, the intensive database query is executed to remain at the server site and the 
less-intensive data for online analysis is processed at the client site. The designation of XML 
schema is the essential factor of Web services for accessing network data. The tree structure 
with hieratical node elements is created in the document of XML schema to record data 
from the web server, and then the XML parser can parse the tree structure by subsequent 
nodes in the schema to retrieve data. The flow chart of parsing process in Fig 2 is separated 
as three parts: (1) converse data as XML document from database based on the specific 
schema, (2) parse XML document through SAX (Simple Application-programming-interface 
for XML) standard, and (3) retrieve data of XML document by scheme definition. The 
interactive data required by QOL assessment and guideline conduction are then 
transformed as Web services documents. The historical clinical data redeemed by expert 
opinions will feedback to data warehouse; and, the online computation models retrieve 
decision criteria from unified documents to display statistical charts. Herein, the WS model 
is integrated with the ORM model to share the QOL questionnaires as the over the Web-
based system for indexing and reorganizing the clinical database. 
 
Fig. 2. Parsing procedure for light-weight data with XML schema. 
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progressed while accessing the database server; thus, the risk evaluations embedded within 
online session logs are efficiently retrieved as connecting the web server. The progress may 
keep complex query behind data mining for the knowledge bank but remain simple data 
transaction through dynamic views in data warehouse. Based on the MVC architecture, the 
online clinical informatics can be achieved by the OLAP mechanism. For example, the 
clinician is a decision maker on a presentation stage that performs the components of the 
interactive guideline and real-time diagrams in clinic. 
2.6 Asynchronous JavaScript XML-HttpRequest model 
The asynchronous JavaScript XML-HttpRequest (AJAX) technique has been widely applied 
for online interactive interface in the past years to grab instant information as well as to 
avoid lag in transportation of client-server data. It can be developed as diverse, convenient, 
and interactive applications with visualized functions for user-friendly interface design. The 
basic concept of asynchronous data transformation is storing transient data at client sites to 
reduce redundant data query with database sites and enhance interactive patient- and 
clinician-oriented interface. Adaptive with the client-server network architecture, it may 
process numerous data queries between the database and the web server. Technically, 
persistent and large data transaction might downgrade the network speed. As the WS and 
OLAP models communicate with the client browser for adopting light-weight data like QOL 
questionnaires, risk evaluations or guideline indexes, the AJAX model helps in adjusting 
data interaction performance. The method doesn’t need to request database all the time but 
load into browser’s temporary container at client site. If the client site keeps sessions at 
online status, the browser is calling JavaScriptTM and restoring data. Once the session needs 
reconnection or updating, the client-server communication is activating. The manner can be 
approved by AJAX that is a standards-based programming technique to make web-based 
applications more responsive, interactive, and customizable in addition to reduce network 
latency and interface complexity for keeping server responsiveness (Smith, 2006). 
In short, the proposed RTCDSS remains heavy-weight database query at server site and 
keeps light-weight data for online analysis at client site to improve clinical data transaction 
efficiently. In the system, clinical data are analyzed to yield expert opinions for feedback to 
clinical data warehouse. Through models of ORM, WS and OLAP, the decision criteria and 
interactive guidance are displayed by AJAX with real time online diagraphs. Based on the 
MVC and CDW, the web and database servers are collaborative within the network services. 
3. Design of patient and clinician oriented interfaces 
This section aims to integrate previous models with practical clinical interfaces for both of 
patients and clinicians. In which, prostate cancer is selected for the sample of modeling since 
it is the chronic disease with a traceable marker for long-term monitoring. Two types of 
interfaces are addressed below for processing PRO with clinical infometrics and analyzing 
PCRs upon the EBM. The entire infrastructure is designed with five primary layers to (1) 
acquire patient-reported outcomes at the “acquisition”, (2) present online clinical diagraph 
at the “presentation”, (3) manage clinical information at the “management”, (4) analyze 
patient’s clinical records at the “analysis”, and (5) coalesce diverse clinical databases at the 
“database”. The structure is exampled by the project named clinical infometrics for prostate 
cancer (CIPC) in China Medical University Hospital (CMUH) in Tahchung, Taiwan. 
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3.1 Patient-oriented interface 
The ORM and CDW models are driven for the patient-oriented interface to collaborate 
clinical measurements with medical informatics through Internet. A knowledge bank is 
generated in database with feedback of expert opinions that provide clinicians real time 
guidance. Instant assessment of patients’ QOL is acquired to compare with clinical markers. 
3.1.1 QOL assessment 
Herein, an infometrics system upon real time online assessment is developed for prostate 
cancer patients. It is employed by the RTCDSS to generate psychometrical modules upon 
information technique to measure patient’s QOL. The assessment results can be instantly 
reported while patients are conducted to easily complete questionnaires on the interface of 
patient-oriented design. Compared to importance of survival evaluation, QOL becomes a 
significant index of healthcare. EORTC creates series of QOL assessments in cancer clinical 
trials to provide a more accurate evaluation of the well-being of individuals or groups of 
patients and of the benefits and side-effects that may result from medical intervention. The 
reliability, validity and sensitivity of assessment are acceptable since questionnaires have 
been validated by more than 3,000 studies worldwide. The quality of life questionnaire 
(QLQ) C30 is developed to assess the QOL of cancer patients while the PR25 is designed for 
prostate cancer patients. In the CIPC, a web-based platform with infometrics system is to 
serve prostate cancer patients. The questionnaires are adopted from EORTC, thus QLQ C30 
and PR25 are the primary assessment modules for volunteer patients in pilot study. The C30 
involves 9 multi-item scales for 5 functional scales (physical, role, cognitive, emotional, and 
social), 3 symptom scales (fatigue, pain, and nausea and vomiting), and 1 global health QOL 
scale, while several single-item symptom measures are also included (Aaronson, N.K., et al., 
1993). The PR25 is a 25-item questionnaire for use among patients with localized and 
metastatic prostate cancer. It has subscales assessing urinary symptoms (9 items), bowel 
symptoms (4 items), treatment-related symptoms (6 items) and sexual functioning (6 items). 
3.1.2 Clinical implementation for prostate cancer 
QOL is an important healthcare index but patients probably conceal the truth because of 
private manners. In addition, the traditional paper-based QOL assessment usually causes 
reading difficulty for patients because of improper font size and print space. Hence the 
infometrics module of CIPC system is designed for patient orientation through sufficient 
accessibility and accompanies QLQ with instant PRO analysis and evaluation. In which, the 
fonts of questionnaires are enlarged for elderly patients who have poor eyesight and the 
selection buttons are displayed on a touch screen for patients who are not familiar with 
using computer mouse. Most of prostate caner patients are seniors who initially might not 
know how to click mouse-button or scroll the browser to navigate the computer; therefore 
the Web-page design is simplified by one-touch action per question before the users are well 
trained. Besides, a multimedia function played with head phones is optionally provided for 
low education level patients who could read questions with limited literacy. Patients are 
arranged privately in a consulting room to complete the questionnaires while waiting for 
the clinicians. Then, through automatic computation and statistical models, the clinicians 
could immediately evaluate the real time reports with online analysis. Based on the system 
design, clinicians and researchers can immediately access infometrix data after patients 
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completed the questionnaires. Fig 3 performs the operating procedure, in which the clinician 
can make cross compare overall treatment information with instant expert opinions for 
advanced communicate with patients. 
 
Fig. 3. Clinic progress implemented with clinical infometrics system. 
Furthermore, the network of CIPC needs to link hospital and campus networks, but under 
hospital’s information security policy, to collaborate tiers of database, analysis, 
management, presentation, and acquisition for clinical and research workflows. As shown 
in Fig 4, the database tier supports clinical and infometrix data warehouse; the analysis 
tier assists analysts analyzing data and feeds back statistical results as resource of the  
 
Fig. 4. Network infrastructure of the CIPC system with RTCDSS components. 
Hospital
Information
System
(HIS)
Campus NetworkClinic Network
Requ
est PR
O & P
CR
Input QOL
CIPC Server
Computation
Workstation
Firewall
Database port
Concurrent Server: 
Web Application + 
Instant Database
Backend Server:
System Development +
Analysis Database
Legacy HIS 
Database
Hospital Intranet Campus Internet
System Update
Clinical & 
Informatics 
Database
P
atient C
linical R
ecords
H
IS
 D
ata
Database Backup
(Analysis
Tools)
Analyst
Fe
ed
ba
ck
 in
fo
rm
at
ic
s
Acquisition Tier
Presentation Tier
Analysis Tier
Database Tier
System
Administrator
Management Tier
Data 
Conversion
Management 
Interface
Privilege 
Administration
Online Chart
Decision 
Support
Statistics 
Tools
Analysis 
Module
Data 
Mining
QOL
Assessment
Interactive
Guideline
Clinicain
Client Browser
Patient Accessibility
Equipment
Client-site Browser
User Interface
AJAX 
Engine
Ja
v
aS
cr
ip
t
H
T
M
L
, 
C
S
S
Server-site System
Web / XML Server
Data Store
Backend 
Platform
X
M
L
 D
at
a
H
T
T
P
 R
eq
u
est
AJAX
Components
Patient
Clinician
Researcher
QoL 
Assessment
Cross 
Analysis
Patient 
Clinical 
Records
Download
Clinical
Decision 
Support
Expert 
Opinion
Analyze Feed Back
Consulting Room
Clinic
Institute
Data 
Integration
QoL
Domains
www.intechopen.com
 Medical Informatics 
 
120 
knowledge bank; the management tier is the control center for administrating data flow 
throughout the entire system; the presentation tier presents real-time functions for online 
decision support and interactive guideline on a friendly interface for P2C communication; 
the acquisition tier becomes the data collector to execute online QOL assessment with 
accessibility interface. The infrastructure bridges both networks of clinics and campus 
through the firewall to routinely backup clinical data and maintain the CIPC system. 
3.2 Clinician-oriented interface 
The clinician-oriented interface is established by MVC model to help analyzing pretreatment 
parameters for clinical evidences. The system can be constructed by the open source 
frameworks with the graphical diagrams to combine PCRs and biomarkers from diverse 
database through networks. In the CIPC, the interface can guide clinicians to concurrently 
collect and analyze specific clinical markers with instant diagrams for prostate cancer 
patients. By referring suggestions from participant clinicians for long-term tracking, we 
herein create computation models based on statistical algorithms to respond expert 
opinions. 
3.2.1 Prostate cancer treatment 
Several pretreatment parameters and clinical markers are significant for tracking the disease 
condition of prostate cancer patients periodically. The CIPC system is proposed in urology 
clinic for reflecting relationship between QOL and pretreatment parameters such as PSA, 
clinical classification stage, and Gleason score, etc. Prostate cancer rarely causes symptoms 
early in the course of the disease. Suspicion of prostate cancer resulting in prostatic biopsy is 
most often raised by abnormalities found on digital rectal examination (DRE). The presence 
of systemic symptoms as a result of prostate cancer suggests locally advanced or widely 
metastatic disease. Growth of prostate cancer into the urethra or bladder neck can result in 
obstructive and irritative voiding symptoms (Carter et al., 2007). Prostate cancer has greatly 
benefited from the discovery of tumor markers. Instant observation and comparison of PRO 
and PCR can be tracked by auto-analysis prior to clinics. 
PSA has evolved for the detection, staging, and monitoring of men diagnosed with prostate 
cancer since its discovery in 1979 to clinical application in the late 1980s through 1990s 
(Sensabaugh, 1978). Most prostate cancer arises as clinically nonpalpable disease with PSA 
between 2.5 and 10 ng/mL. The stage regarding how far the tumors have spread for 
defining prognosis and selecting therapies, and has become an important marker as 
evaluating prostate cancer. The four-stage TNM system, which includes the size of the 
tumor (T), the number of involved lymph nodes (N), and the presence of any other 
metastases (M), indicate how far the cancer has spread for defining prognosis and selecting 
therapies. Among urologic malignancies, the combination of DRE and serum PSA is the 
most useful first-line test for assessing the risk of prostate cancer. Particularly, the initial 
PSA value after a treatment is the most useful clinical information for detecting, staging, and 
monitoring prostate cancer patients when assessing the risk of prostate cancer (Partin et al., 
1997; Pound et al., 1999). The clinical variables can be retrieved from databases of HIS 
through different networks. 
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i. PSA Level 
The presence of prostate diseases is the most important factor affecting serum levels of PSA 
(Wang et al., 1981; Ercole et al., 1987). Many studies have made efforts to evaluate other 
thresholds to maximize the positive biopsy rate of PSA-based screening (Gann et al., 1995). 
The PSA-related parameters including PSA density (PSAD), PSA velocity (PSAV) and PSA 
doubling time (PSADT) are considered to improve diagnostic accuracy of PSA. A direct 
relationship between PSAD and the likelihood of cancer has been documented (Bazinet et 
al., 1994), and higher PSA densities may be found among groups of men with positive 
biopsies compared with men with negative biopsies (Uzzo et al., 1995). PCRs can be filtered 
to rank high risk patients who have relatively smaller prostate volumes when a constant 
number of biopsies are obtained. 
PSAV is the rate of change in serum PSA. A rate in excess of 0.75 ng/mL per year is a 
significant indicator of prostate cancer for prediction of prostate cancer (Carter et al., 1992; 
D'Amico et al., 2005). PSAV can be estimated by substituting PSA data into the linear 
regression equation as Eq.(1) that formulates the arbitrary PSA (Pi) with respect to time (Ti). 
 i iP T     (1) 
Where, the parameter  represents the slope of equation and is identical to the PSAV while 
 would be the initial PSA. Ti is available to count by days, months or years. 
PSADT is denoted as the duration when the logarithm of PSA doubles and has been 
evaluated in patients with a rising PSA after local treatment with radiation therapy (Fowler 
et al., 1994). In Eq. (2), we can substitute the regression equation of PSAV into the half-
logarithmic coordinate of ln(Pi) versus Ti, and a straight line is obtained to calculate 
doubling PSA at doubling time TD. 
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The relationship of two arbitrary PSAs measured at the time T1 and T2 with respect to the 
doubling time TD is formulated when ln(2*P1) is estimated. 
ii. TNM stage 
The well-known TNM classification system generally evaluates the size of the tumor (T) by 
four stages, the extent of involved lymph nodes (N) by two stages, and any metastasis (M) 
by two stages. For evaluation of the primary tumor: T1 stage presents tumor, but not 
detectable clinically or with imaging; in T2, the tumor can be palpated on examination, but 
has not spread outside the prostate; the tumor has spread through the prostatic capsule in 
T3 stage; and in T4, the tumor has invaded other nearby structures. For evaluation of the 
regional lymph nodes: N0 present there has been no spread to the regional lymph nodes 
whereas N1 has been spread. For evaluation of distance metastasis, M0 represent there is no 
distant metastasis while M1 has that. In this study, version 6 of the TNM system published 
by the American Joint Committee for Cancer (AJCC) and the International Union against 
Cancer (UICC) in 2002 is adopted. 
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iii. Gleason score 
The Gleason grading system is based on a low-magnification microscopic description of the 
architecture of the cancer and is the most commonly used classification scheme for the 
histological grading of prostate cancer (Gleason, 1966). The predominant pattern that 
occupies the largest area of the specimen is given a grade between 1 and 5. This number is 
then added to the grade assigned to the second most dominant pattern; thus, a Gleason sum 
can be arranged between 2 and 10. This system describes tumors as "well", "moderately", 
and "poorly" differentiated based on Gleason score of 2-4, 5-6, and 7-10, respectively. 
iv. Kaplan Meier survival estimation 
The Kaplan-Meier estimator, which is known as the product limit estimator, estimates the 
survival function from life-time data (Kaplan & Meier, 1958). Let S(t) be the probability that 
an item from a given group of size N will have a lifetime exceeding t. Corresponding to each 
ti is ni, the number “at risk” just prior to time ti, and di, the number of deaths at time ti, 
where i = 1, 2, …, N. Note that ti is equal or less than ti+1 and the intervals between each 
time typically will not be uniform. Then, the estimator is with nonparametric maximum 
likelihood convergence of S(t) in a product of the form 
 
i
i i
it t
n - d
S(t)
n
   (3) 
When there is no censoring, ni is the number of survivors just prior to time ti. With 
censoring, ni is the number of survivors less the number of losses. It is only those surviving 
cases that are still being observed that are “at risk” of an observed death. 
v. Cox Proportional Hazard Model 
Proportional hazards model is a sub-class of survival models well known in statistics by 
consisting of two parts: the underlying hazard function to describe how hazard (risk) 
changes over time; and the effect parameters to describe how hazard relates to other factors, 
e.g. the choice of treatment, in a typical medical example. The effect parameters estimated 
by any proportional hazards model can be reported as hazard ratios. The formula in Eq. (4) 
is recruited for building computation module in the system. 
 
p
i i p
i
h t h t X X X X X0 1 2
1
( , ) ( )exp( ), ( , , )

 X   (4) 
In which, h0(t) is the baseline hazard involving t but not X’s while X denotes a collection of p 
explanatory variables X1, X2, …, Xp and the model is nonparametric because h0(t) is 
unspecified. For PSA variables correlation in prostate cancer treatment, these variables may 
include age, race, initial PSA, PSAV, PSAD, clinical stage, treatment, and so on. 
3.2.2 Instant analytical diagram 
The computation models involve statistical modules to achieve pretreatment parameters for 
clinical requirements. These modules carry out analytical diagrams on the clinician-oriented 
interface for physicians to instantly study tendency of illness conditions according to the 
significant pretreatment parameters below. 
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i. PSA-related information 
The PSA-related information such as PSAD, PSAV and PSADT can be calculated due to 
previous equations and perform real time online analytical diagrams. The graphic interface 
displays instant diagram of PSA baseline with respect to parameters above. The clinicians 
can select required item to present possible velocity and doubling time of PSA by checking 
the date of PSA record from check-box. The diagram can be printed out as the attachment of 
clinical prescription. Furthermore, the survival and hazard estimation modules are available 
for instant crossing comparison to avoid time-consuming manual analysis beyond clinics. 
ii. Partin table 
Gleason grade has been shown to correlate with the pathologic extent of disease but is not 
sufficiently accurate so that Partin tables are usually referred. The Partin tables include 
primary clinical stage, serum PSA level, and Gleason score to determine the probability of 
having a final pathologic stage based on logistic regression analyses for all 3 variables 
combined (Partin et al., 1993; Partin et al., 2001). The table is important in guiding decisions 
for prostate cancer. It is a way of predicting cancer's pathologic stage which is determined 
after the prostate gland has been surgically removed and examined by a pathologist. The 
probability is referred by following the pathologic stages, due to the tables, as (1) organ-
confined disease, (2) established capsular penetration, (3) seminal vesicle involvement, and 
(4) lymph node involvement. If probability of organ-confined disease is high, then early-
stage treatment options are feasible. If the probability of cancer having spread beyond the 
prostate is high, then other treatment options will need to be considered. Herein, the system 
adopts the Partin table guided by the National Comprehensive Cancer Network (NCCN). 
iii. Risk evaluation criteria 
Risk evaluation criteria of prostate cancer is constructed on the basis of large numbers of 
patients who have undergone radical prostatectomy to aid in the precise prediction of 
pathologic stage by using multiple clinical parameters as accurate predictors of both cancer 
extent and long-term outcomes after treatment of the primary tumor (Kleer & Oesterling, 
1993). The criteria as shown in Table 1 (D'Amico et al., 2001) can be adopted to stratify 
patients into low, intermediate, and high risk disease, and to summarize the failure status, 
Risk group Risk factors Risk (a, b, c) % 
Low T1c or T2a and PSA <= 10 ng/ml and Gleason score <= 6 (<25, 85, 83) 
Intermediate T2b or Gleason score = 7 or PSA > 10 and <= 20 ng/ml (25-50, 60, 46) 
High T2c or PSA > 20 ng/ml or Gleason score >= 8 (>50, 30, 29) 
a. Post-therapy PSA failure at 5 yrs; b. PSA failure-free survival at 5 yrs;
c. PSA failure-free survival at 10 yrs
Table 1. Risk Evaluations for Prostate Cancer (D'Amico et al., 2001; Lin et al., 2011). 
Based on the correlations of these pretreatment parameters with the true extent of disease, 
the RTCDSS can integrate the clinical data and expert opinions available for clinicians to 
determine the likelihood of disease progression and predict the pathologic stage. 
3.3 Integration design 
Based on RTCDSS design, the CIPC system is built with open source framework of JavaTM 
technique while Apache TomcatTM and OracleTM are selected as Web and database servers, 
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respectively. The system components with flexible functionality and keep-in-simple-stupid 
(KISS) interface are designed to enhance the human computer interaction. The system 
involves database, analysis, management, presentation, and acquisition layers, from right to 
left in Fig 5, on the modelized architecture by implementing previous methodology. 
 
 
 
Fig. 5. Five-layer development of RTCDSS infrastructure (Lin et al., 2010). 
1. The database layer is the foundation of the system for building clinical data warehouse. 
Fig 6 illustrates the primary object relationship diagram and schema simplified by 
entity relationship diagram (ERD), where the attributes denote correlation between 
QOL domains and treatment effects. The schema combined two sets of fact tables for 
infometrix and clinical records so that “Answer_Full” and “Answer_Domain” tables 
store and transform assessment data to QOL domain score, while “Patient_Info” and 
“Prostate_Cancer” tables retrieve data from PCR. “Answer_Index” is an index table to 
bridge “Answer” and “Question” tables, which request and arrange assessment data, 
and derive cube dimensions of PSA, treatment, clinical stages and Gleason scores. 
2. The analysis layer assists researchers analyzing data and feeds back statistical results as 
resource of knowledge bank. In the practice, several types of data file formats converted 
from database were generated to satisfy different progresses supported by analysis 
tools. The layer incorporates database and application servers with remote computation 
or offline data mining and feed expert opinions back to knowledge bank of RTCDSS. 
3. The management layer plays the role of control center for managing data flow within 
the entire system. A management interface is designed to enhance capability of data 
access functions for health care people and researchers to plot online charts, identify 
single sign-on, process data conversion, administrate user privilege, and acquire QOL 
assessment. All modules are built as objects of models for sharing functionality but 
secured with privilege roles of health care people, clinicians and researchers. 
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Fig. 6. Object relationship diagram and schema (Lin et al., 2010). 
4. The presentation layer is the interface of real time decision support for communication 
of patients and clinicians. The system presented instantaneous statistical diagrams by 
referencing expert opinions from knowledge bank for clinicians. In the CIPC, it 
performs the real time QOL evaluation with respect to mean value of other patients, 
initial PSA, Gleason score, treatment stage, etc. Clinicians are able to indicate treatment 
indexes online through graphical interface for decision support. 
5. The acquisition layer becomes the data receiver of the system to execute QLQ online 
behind accessibility interface design. Perhaps most of patients fell uncomfortable, either 
in physical or mental status, and avoid writing paper sheet by themselves as answering 
the assessment questions. In the practice, the touched screen, the sizeable large fonts, 
and the audio media with ear phones are functioned for more accessibilities of patients. 
Based on the system design, clinicians and researchers are available to access infometrix 
data after patients finished assessments through patient-oriented interface. For securing 
patients’ privacy, the clinical records must be forbidden from internet users except of 
particular clinical people; therefore, the primary database server for instant infometrix 
becomes the data center in clinic site; meanwhile, a backup database server in research site 
allows restore data automatically through specified protocol. 
4. Practice of patient-to-clinician strategy 
The mechanism of innovative CIPC is compiled with online assessments of QOL and PRO 
modules and the interactive interface is functioned for clinical requirement to efficiently 
automate the clinical procedure. Beyond the patient- and clinician- oriented interfaces, the 
P2C communication becomes the strategy through interactive guideline with treatment risk 
evaluation to provide real time references for decision making. For adapting the CIPC with 
the P2C strategy into hospital, quasi-real time data transportation is adopted for flexibly 
arranging administration schedules due to the hospital management policy. 
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4.1 Interactive guideline 
The proposed framework was practiced in the urological cancer department of CMUH. Both 
of the campus and hospital networks were incorporated with heterogeneous database 
management. The necessary prostate cancer data resources were extracted and filtered from 
the cancer data center of CMUH. The interactive guidance design for clinician-oriented 
interface is evaluated with regard to how well it helps clinicians interact with patients and 
provide efficient clinical care. With practice of the CIPC system, PROs with QOL can be 
collected through clinical infometrics and be referred by interactive guidelines for clinical 
decision support. Herein, the guideline with QOL domains, risk evaluation table, interactive 
treatment chart, and automated prescription will be discussed. Through the RTCDSS, the 
approaches regarding clinical infometrics for patient outcome collection of QOL and 
interactive guideline for clinical decision support will be highlighted below. 
i. Statistics of QOL domains – The diagram on Fig 7 lists details of the last assessment 
results involving the questionnaires, range and scale in each domain, effect and missing 
items while answering questions. All QOL domains reflect the functions and symptoms 
of a patient in physical and mental conditions during the treatment cycle. Clinicians can 
realize statistic results of patient’s disease conditions at the beginning of clinic. The 
historical QOL scores with PSA values shown in Fig 8 provide an overall chart for 
clinician and patient. It helps the patient describe their real health condition to avoid 
ambiguous conversation. 
 
Fig. 7. Statistics of QOL domains (Lin et al., 2010). 
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Fig. 8. Graphical QOL diagram with clinical marker - QOL vs. PSA baseline (Lin et al., 2010). 
ii. Disease evaluation of the PSA level – Fig. 9 shows the PSAV and PSADT values with 
PSA baseline while the clinician enters the patient’s ID and selects an arbitrary time 
interval. The real-time diagram shows the disease information of the patient’s PSA level 
throughout different treatments. It can be seen that the system retrieved the patient’s 
data from PCRs and listed related pretreatment parameters for an overview of the 
patient’s disease history. The baseline of PSA is completely plotted during different 
treatment cycles with significant points (such as the initial PSA) of note. 
 
Fig. 9. Interactive guidance to help computing PSA-related data online (Lin et al., 2011). 
iii. Risk guidance with the Partin table – Using the Partin table module in the system, the 
clinician can easily find and input pretreatment parameters such as PSA, Gleason score, 
and a clinical stage to determine the risk percentage shown in Fig 10. The clinician can 
find and input pretreatment parameters like PSA, Gleason score and clinical stage for 
determining the risk percentage. In this case, the clinician input T1c, 32.4, and 5-6 for 
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TNM stage, PSA value and Gleason grade, respectively; the system immediately 
estimated risk percentage in high risk group due to Table 1 that shows more than 50% 
for 5 years of post-therapy PSA failure as well as 30% and 29% for 5-year and 10-year 
PSA failure-free survival, respectively. 
 
Fig. 10. A screen shot of real-time decision support that the clinician can use to evaluate the 
recurrence risk and the Partin table online by flexibly adjusting clinical data (Lin et al., 2011). 
iv. Interactive guidelines for treatment reference – Clinicians can interact with the 
guideline thus the phase of treatment procedure based on the criteria are carried out for 
decision making as PCRs are input. For example on Fig 11, if the PSA was 25.5ng/ml, 
the clinical stage was T3, Gleason score was 8, life expectancy was more than 5 years,  
 
Fig. 11. Interactive guideline of CIPC system for overview guidance that can highlight a 
suitable prostate cancer treatment flow based on a patient’s clinical data. 
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with symptomatic therapy as bone scan; the blue region will pop up for overview and 
be duplicated to the bottom area of the screen to signify the cure steps for reference. 
Meanwhile, the risk evaluation will be highlighted by yellow mark at the right side. By 
providing a comparison with the non-highlighted steps on the overview of guideline 
flow, the flowchart allows the clinicians to identify the current stage and see what the 
next step is. 
v. Special diagnostic chart for automated prescription – To prevent typing error by 
clinicians as input electronic PCRs, the design of special diagnostic chart lists primary 
clinical markers for selection. Fig 12 displays an interface that the clinician can select 
required item to immediately produce unified statement of automated prescription as 
concurrently inputting data into the database for related hospital information systems. 
 
Fig. 12. Clinical interfaces of special chart and automatic prescription. 
4.2 P2C communication 
Before development of the CIPC, prostate cancer patients were tracked by handwriting QOL 
assessments during cure period but lacks of automatic electronic progress. Because of 
physical or mental suffering, patients used to complete paper works through conversation 
with health care people. Meanwhile, doctors took many efforts to explain PROs at clinic 
time by printing out PCRs for advices. Therefore, the RTCDSS was established by practical 
requirements on increasing interaction with patients to consolidate relationship as well as 
reducing official burden of health care people. Following the CIPC procedure mentioned in 
Fig 3, moreover, all personal data were encrypted as being written into the database to 
avoid being falsified and stolen. Hence patients have enough confidence under risk 
avoidance to comply with clinicians’ guidance. In the practice, patients read the 
introduction and login with personal ID to start the QOL assessment. As shown in Fig 13, 
there’s only one question per browser page and the patient can adjust suitable font size on 
the touched screen in addition to consider the voice control button for assistance. On the 
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other hand, the clinician is able to compare patient’s record with others who meet similar 
markers and evaluate assessment results by figures or charts for advanced consultation. 
 
Fig. 13. Screenshot of QOL questionnaire page of CIPC system for prostate cancer patients. 
i. Cross comparison – the example chart shown in Fig 14 supports the clinician and patient 
to take an overview for discussing the variation of QOL compared with the mean value 
of other patients in similar conditions. It enhanced the patient with confidence to follow 
doctor’s comments for advanced treatment. In the pilot study, patients reflected 
motivation with more interaction to clinicians as recognizing QOL history with clinical 
markers. 
 
Fig. 14. Cross comparison after assessment (Lin et al., 2010). 
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ii. Overall evaluation – Fig 8 displays the change of QOL, which became better after some 
particular time because of the successful prostate surgery. Referring the PSA history 
compared with selected QOL domains, patient’s PSA was improved after accepting 
surgery operation in early 2007. However, a suspected point was observed in the period 
around July in 2007 under stable PSA baseline, the patient felt uncomfortable since the 
physical function was suddenly getting worse while the diarrhoea symptom became 
significant. It assisted the clinician recognizing whether the problem was caused by the 
prostate disease. 
iii. Real time informetrix categories for patients – The best practice of the developed system 
should be applied for patients whose disease can be chronically and periodically 
tracked by specified clinical markers. Therefore the design of real time infometrix for 
prostate cancer patients displays their PSA values associated with QOL domains to 
provide categories of physical, role, cognitive, emotional, and social functions in 
addition to that of fatigue, pain, nausea and vomiting symptoms. Particularly, it reflects 
urinary, bowel, treatment-related symptoms and male-related sexual functioning. 
Patients can recognize personal health condition immediately with respect to others 
through the instant graphical chart in the clinic. 
From aspect of participant clinicians, they use the system mainly for functional assessment 
as well as for highlighting patients' most bothersome symptoms. The most common benefits 
would include enhancing communication with patients, identifying under-reported 
symptoms for clinicians and increasing efficiency in clinics. To assess the advantage of the 
developed system for users, some interesting problems are observed and discussed below. 
i. Online informatics for clinicians – The greatest advantage conferred by this system is its 
ability to assist in the treatment of chronic diseases that can be periodically tracked 
using the specific clinical variables as shown in Fig 9. The online informatics displays 
PSA-related data to provide categories of diagnostic information. Clinicians can identify 
patients’ health conditions directly with respect to treatments through the instant 
diagrams. The participants reported that the RTCDSS saved hours, even several days, 
of analysis for them by providing instant computation of the relevant parameters. 
ii. Improvement in clinician-patients relationships – Several studies in chronic diseases 
suggested that feedback of health status data may facilitate communication between 
patients and clinicians to enhance patients’ care (Kazis et al., 1990; Wagner et al., 1997). 
Accordingly, incorporating QOL assessments in routine clinical oncology practice can 
heighten physicians’ awareness of their patients’ (Detmar et al., 2002). In the CIPC, 
clinicians predicted potential disease risk as shown in Fig 10. Thus, the clinician could 
refer to the interactive guideline in Fig 11 while offering the suggestions, ordering the 
proper treatment, and tracking the follow-up conditions. Correspondingly, the system 
assists clinicians to discover reliable QOL information of patients since they would like 
to confess more factual illness status. The auto-data transportation procedure 
minimizes manual mistakes to ensure data quality and confirm the RTCDSS has 
capacity to improve clinician-patient relationships. 
iii. Enhancement in P2C communication – Both of online infometrics and interactive guideline 
in routine clinical practice can enhance clinicians’ awareness of their patients’.  Herein, 
clinicians use the developed system to discover reliable predictive information for 
prostate cancer patients through real time statistics and computation. Therefore, 
manual mistakes can be eliminated by the automatic transportation procedure to ensure 
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data quality.  It confirms that the framework of the real time CIPC system is possible 
and feasible to improve communication between patients and clinicians. 
4.3 Advantage and difficulty 
The biggest benefits of CIPC system would likely enhance clinical care for patients, support 
optimal treatment options for clinicians, and increase efficiency in clinics. The advantages of 
the developed system can be summarized: (a) ensuring quality of clinical care, (b) providing 
the clinicians real-time online clinical informatics, (c) enhancing P2C communication, and (d) 
improving clinician-patients relationships. Behind the successes above, however, the past 
studies also experienced difficulties as practicing the new system restricted by management 
policies and a flexible strategy is considered to satisfy the actual condition. The hospital 
management and security policy limited the CIPC system only work partially for proposed 
clinic beyond the hospital network. As adapting the system to the legacy HIS, noises of diverse 
systems are always counted for integration. The structural reformation on original HIS should 
be avoidant but through gradual data immigration under administration rules. 
Herein, the CIPC system was installed in the server at the urology clinics in which an 
individual patient used to make appointment on a specific day of week. In compliance with 
hospital management for safety policy, the power of clinic room was turned off after clinics 
and the CIPC server must be shutdown. To avoid conflicting with the HIS but ensure data 
transformation can synchronize between inconsistent systems, a process scheduling module 
was employed for data importation between the HIS and CIPC system. The module was 
embedded in both systems to retrieve required data from the backup log of CIPC system at 
a specified time point and transform data into the HIS database. As a result, clinicians could 
obtain the last patient outcomes if their data were imported into the HIS just before clinic 
time. Fig 15 illustrates three data-update jobs in a cycle as considering two scheduling points  
 
Fig. 15. Processes scheduling of data transformation for heterogeneous system integration. 
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before and after the clinics. At the first point in the first clinic, the required data are 
replicated into the backup log. In the cycle, clinicians activate the start button to load PCRs 
and clinical markers from the log into CIPC database; and then, the new outcomes will be 
input during clinic time. After the clinic, clinicians can update complete remarks of PCR to 
CIPC database and all data will be restored to the backup log concurrently. At the second 
point in the last clinic, the log will be retrieved in schedule and be transformed into the HIS. 
Once the CIPC server is activated, the scheduling will be automatically started. In the study, 
the process scheduling was executed twice per week by urological clinics. The “quasi real 
time” strategy above can help solving the difficulty while implementing a new development 
into the legacy system under management restriction. 
4.4 Practice discussions 
The system confers the following benefits: (1) clinicians can explain health conditions clearly 
to patients by visualized clinical variables and pretreatment parameters; (2) patients are 
more easily convinced by evidence-based diagrams before accepting the risk evaluation of 
treatments and the treatment quality can be confirmed; (3) the design presents real-time 
disease and risk evaluation while the interactive guidelines with treatment suggestions offer 
the clinician efficient online tools for instant decision making; (4) the proposed framework is 
constructed upon the Web-based MVC architecture that consists of reusable models, making 
it flexible and adaptable with many hospital information systems. In the pilot study, more 
than 90% of users approved the innovative design. Clinicians learned more reliable 
information regarding patient’s private QOL. The efficient diagnosis and communication 
certainly encourages the advanced study. With RTCDSS for predicting treatment assistance, 
diverse functionalities can be expectant for advance clinical decision, context-specific access, 
automatic risk assessment, personal digital assistant screens, as well as practitioner 
performance and cost-effectiveness on patient outcomes (Aaronson et al., 1993). In the 
future, the real-time decision support functions can be expanded flexibly by involving other 
diagnostic variables and modern technologies like RNA and DNA studies. It can also 
incorporate with advanced prediction models such as nomograms, which may help patients 
and their treating physicians make informed decisions based on the probability of a 
pathologic stage, the patient’s risk tolerance, and the values they place on the various 
potential outcomes (Stephenson et al., 2005). The system will aid the rational selection of 
patients to undergo definitive therapy. 
5. Conclusion remarks 
This study reveals clinical and infometrics progress with information technology to establish 
fundamentals of the RTCDSS. Methodologies include MVC architecture, Web services, online 
analytical process, clinical data warehouse, object relation mapping, and AJAX while the 
practical CIPC system is implemented for approval. The infrastructure integrates five layers to 
establish expandable models with flexibility for providing accessible functions in clinic 
applications of prostate cancer. Heterogeneous database systems distributed in hospital, clinic 
and campus networks were integrated for an expert bank with remote data backup and 
disaster recovery. A patient- and clinician-oriented interface is considered as a major subject to 
assist P2C communication. In advance, the patient outcome is available to offer instant 
statistical charts for decision making as well as improved communication and relationship 
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between clinicians and patients. Furthermore, the RTCDSS enables interactive guideline for 
knowledge feedback, facilitate decision-making, and to improve quality of care. 
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